510(k) Report

510(k) · Cleared

Cleared

Bodyport Cardiac Scale

K211585510(k) TraditionalCleared Jul 29, 2022431-day reviewClass II21 CFR 870.2770

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bodyport, Inc. · DSB Plethysmograph, Impedance

Cleared on Jul 29, 2022 as substantially equivalent to K133301 (Noninvasive Medical Technologies, Inc., 2014) after a 431-day review. Its family tree reaches back 5 generations to 1992.

Decided
Jul 29, 2022
Review
431 days
Class
Class II
Product code
DSB
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K922218 (1992). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK922218 IQ SystemRenaissance Technology, Inc. · 1992
  2. 4 generations backK042113 Zoe Fluid Status MonitorNoninvasive Medical Technologies, LLC · 2004
  3. 3 generations backK112830 Zoefluid Status Monitor (Model Zoe 2B)Noninvasive Medical Technologies, Inc. · 2012
  4. 2 generations backK131509 Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc. · 2013
  5. 1 generation backK133301 Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc. · 2014
  6. This deviceK211585 Bodyport Cardiac ScaleBodyport, Inc. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K922218IQ SystemRenaissance Technology, Inc.1992—
−4K042113Zoe Fluid Status MonitorNoninvasive Medical Technologies, LLC2004—
−3K112830Zoefluid Status Monitor (Model Zoe 2B)Noninvasive Medical Technologies, Inc.2012—
−2K131509Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc.2013—
−1K133301Zoe Fluid Status MonitorNoninvasive Medical Technologies, Inc.2014—
0 (this device)K211585Bodyport Cardiac ScaleBodyport, Inc.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
FIG. 1 — Lineage of K211585, 1992–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSB device

  1. #1 K232089 SOZO Proscore 14.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133301Zoe Fluid Status Monitor
Summary page 4
…DSB Predicate Device(s): Noninvasive Medical Technologies, Inc.’s ZOE Fluid Status Monitor Model ZOE3 (K133301) Reference Device(s): N.I. Medical, Ltd.’s NICaS 2001 Noninvasive Cardio-Respiratory…
Noninvasive Medical Technologies, Inc.2014—
†K942227Nicas 2001 Noninvasive Cardio-Respiratory SystemC.L. Mcintosh & Assoc., Inc.1996—
†K172507SOZOImpediMed Limited2017—

Also cleared against K133301: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 4 companies; a new generation was cleared every 8.2 years on median.
  • None of the 6 ancestors has a recall.
  • 4 other devices also cite its predicate K133301.

How does its category compare?

All DSB devices

DSB Plethysmograph, Impedance: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · DSB

3in 2025

2007: 22008: 62009: 22010: 12011: 22012: 12013: 22014: 22015: 22017: 22018: 12019: 12020: 22021: 12022: 12023: 22025: 32026 (partial year): 1
2007high 6 (2008) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSB

266in 2025

2008: 90 days median2025: 266 days median
2007high 266 (2025) · low 90 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSB

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSB

2in 2025

2016: 12025: 2
2007high 2 (2025) · low 0 (2007)2025

MAUDE reports naming product code DSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200869000
20092—00
20101—00
20112—00
20121—00
20132—00
20142—00
20152—10
20160—01
20172—00
20181—00
20191—00
20202—00
20211—00
20221—00
20232—00
20240—00
2025326602
20261—0—

What is it indicated for?

The Bodyport Cardiac Scale is intended for use, under the direction of a physician, for the non-invasive monitoring and management of patients with fluid management related health conditions. The device is intended to be used to measure and track body weight, peripheral impedance, pulse rate, and center of pressure. The device is intended to be used in the home or clinic environment. Intended users are people over 21 years of age who can stand for the…

Read the full statement (129 words)

The Bodyport Cardiac Scale is intended for use, under the direction of a physician, for the non-invasive monitoring and management of patients with fluid management related health conditions. The device is intended to be used to measure and track body weight, peripheral impedance, pulse rate, and center of pressure. The device is intended to be used in the home or clinic environment.

Intended users are people over 21 years of age who can stand for the duration of the measurement and weigh less than 180 kg (397 lbs).

The device does not generate any real-time alarms for consideration by the user at home or by a healthcare professional. Data from the device should be used in the context of all clinical data to make determinations of a patient’s status.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211585: Bodyport Cardiac Scale.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211585

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026